CNTG | Centogene N.V. | [NASD]
Index- P/E- EPS (ttm)-2.52 Insider Own20.83% Shs Outstand27.60M Perf Week-0.93%
Market Cap22.37M Forward P/E- EPS next Y-1.08 Insider Trans0.00% Shs Float10.13M Perf Month5.42%
Income-61.10M PEG- EPS next Q-0.38 Inst Own66.80% Short Float / Ratio0.50% / 0.05 Perf Quarter-25.25%
Sales101.30M P/S0.22 EPS this Y-22.70% Inst Trans-0.70% Short Interest0.05M Perf Half Y7.77%
Book/sh0.27 P/B2.96 EPS next Y31.20% ROA- Target Price1.50 Perf Year-70.63%
Cash/sh1.40 P/C0.58 EPS next 5Y- ROE- 52W Range0.61 - 2.92 Perf YTD-11.58%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-71.84% Beta-0.92
Dividend %- Quick Ratio2.40 Sales past 5Y8.40% Gross Margin17.40% 52W Low34.80% ATR0.12
Employees808 Current Ratio2.40 Sales Q/Q57.30% Oper. Margin- RSI (14)49.70 Volatility8.42% 13.09%
OptionableNo Debt/Eq8.15 EPS Q/Q- Profit Margin- Rel Volume0.04 Prev Close0.81
ShortableYes LT Debt/Eq7.22 Earnings- Payout- Avg Volume971.18K Price0.82
Recom2.00 SMA202.41% SMA503.28% SMA200-19.25% Volume17,552 Change1.39%
Date Action Analyst Rating Change Price Target Change
Aug-05-21Resumed Credit Suisse Outperform $14
Apr-24-20Downgrade Evercore ISI Outperform → In-line $21
Dec-03-19Initiated Robert W. Baird Outperform
Dec-02-19Initiated Evercore ISI Outperform
Dec-02-19Initiated BTIG Research Buy
May-16-23 06:25PM
May-05-23 06:30AM
Apr-28-23 06:30AM
Apr-26-23 04:14PM
08:00AM Loading…
Apr-14-23 08:00AM
Apr-12-23 06:30AM
Apr-11-23 06:30AM
Mar-09-23 06:30AM
Mar-08-23 06:30AM
Feb-22-23 09:40AM
Feb-21-23 06:30AM
Feb-07-23 08:00AM
Jan-10-23 08:00AM
08:30AM Loading…
Jan-09-23 08:30AM
Dec-28-22 06:30AM
Dec-24-22 08:24AM
Dec-22-22 04:00PM
Dec-16-22 04:30PM
Dec-01-22 06:30AM
Nov-23-22 12:59PM
Nov-21-22 06:30AM
Nov-10-22 06:30AM
Nov-03-22 06:00AM
Oct-06-22 06:00AM
Oct-03-22 08:00AM
Sep-01-22 06:30AM
Jul-15-22 08:15AM
04:01PM Loading…
Jun-27-22 04:01PM
Jun-13-22 06:30AM
Jun-02-22 05:25PM
May-25-22 05:35PM
May-23-22 06:30AM
May-19-22 06:30AM
May-06-22 08:01AM
Apr-28-22 06:30AM
Mar-30-22 01:00PM
Mar-24-22 06:30AM
Mar-23-22 06:30AM
Mar-17-22 06:30AM
Feb-22-22 06:30AM
Feb-08-22 06:30AM
Feb-01-22 08:24AM
Jan-20-22 06:30AM
Jan-04-22 08:00AM
Dec-23-21 08:00AM
Dec-20-21 08:30AM
Dec-18-21 07:17AM
Nov-24-21 08:55AM
Nov-18-21 06:30AM
Nov-04-21 06:30AM
Oct-28-21 06:30AM
Oct-19-21 07:20AM
Oct-06-21 08:00AM
Sep-30-21 07:05AM
Sep-29-21 05:05PM
Sep-07-21 04:00PM
Sep-01-21 06:30AM
Jul-27-21 06:30AM
Jun-25-21 06:30AM
Jun-22-21 06:30AM
Jun-19-21 04:34AM
Jun-16-21 08:00AM
Jun-15-21 08:14AM
Jun-09-21 04:30PM
Jun-07-21 07:23AM
Jun-04-21 10:07AM
Jun-02-21 06:31AM
Jun-01-21 06:30AM
May-26-21 06:30AM
May-18-21 06:30AM
May-10-21 06:30AM
May-07-21 06:32AM
May-06-21 06:30AM
May-05-21 06:30AM
May-04-21 11:04AM
May-03-21 11:50AM
Apr-20-21 01:19AM
Apr-19-21 03:12AM
Apr-15-21 06:30AM
Apr-14-21 06:30AM
Apr-08-21 06:30AM
Mar-09-21 06:30AM
Feb-18-21 01:59AM
Dec-18-20 10:02AM
Dec-16-20 07:03AM
Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.